JD

Jagdish Deb

Active Director Director DIN 07909174
DIN 07909174 First appointment Sep 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2017
Shareholding value •••• Premium profile

About Jagdish Deb

Data last updated:

Jagdish Deb is a Director at Wrest Healthcare Private Limited (since 2017). The company operates in Pharma. Wrest Healthcare Private Limited reported revenue of ₹6.61 Cr (FY 2024).

DIN 07909174
Primary Designation Director
Industry Pharma
First Appointment 05 Sep 2017
Oldest Company Age 9 yrs
Largest company Wrest Healthcare Private Limited · ₹6.61 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Wrest Healthcare Private Limited U74999AS2017PTC018138
Director05 Sep 20172017₹6.61 Cr (FY 2024)Active

Board colleagues of Jagdish Deb

NameDINCompanyDesignation
Joydeep Deb07016433Wrest Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Wrest Healthcare Private Limited
Premium access

Shareholding and investment profile for Jagdish Deb

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jagdish Deb

Jagdish Deb currently holds 1 directorship: Wrest Healthcare Private Limited (Director, since 05 Sep 2017, revenue ₹6.61 Cr (FY 2024)).

Jagdish Deb was first appointed on 05 Sep 2017 as Director at Wrest Healthcare Private Limited.

The current boards of Jagdish Deb's companies include Joydeep Deb (Wrest Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available